


Capital appreciation.
| Name | % Net Assets |
|---|---|
| Pfizer | 4.4% |
| US Treasury N/B 0.875% 2016-11-30 | 3.6% |
| US Treasury N/B 0.375% 2015-03-15 | 3.6% |
| Aviva | 3.1% |
| BT Group | 3.1% |
| Sumitomo Mitsui Financial Group | 3.1% |
| Sara Lee | 2.9% |
| Pearson | 2.5% |
| Royal Bank of Scotland | 2.3% |
| Nippon Telegraph and Telephone | 2.3% |
| Key | % Net Assets |
|---|---|
| 4.4% | |
| 3.6% | |
| 3.6% | |
| 3.1% | |
| 85.3% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 4,473.85p |
| Currency | GBP |
| Change | -41.20p |
| % | -0.91% |
| YTD change | -138.28p |
| YTD % | -3.00% |
| Fund Inception | 09/01/1984 |
|---|---|
| Fund Manager | Andrew Green |
| TER | 1.70 (31-Dec-2010) |
| Minimum Investment | |
|---|---|
| Initial | £6000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.35% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.09 |
You are here: research